Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Donnelly

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|August 16, 2002
Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazolRichard Donnelly
Diabetes, Obesity & Metabolism|February 16, 2007
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetesRichard Donnelly
Diabetes, Obesity & Metabolism|January 25, 2003
Researching new treatments for obesity: from neuroscience to inflammationRichard Donnelly
Diabetes, Obesity & Metabolism|October 14, 2004
ACE inhibitors and cardiovascular protection in diabetesRichard Donnelly
International Journal of Molecular Sciences|November 3, 2020
Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary SyndromeXianqin Qu, Richard Donnelly
Current Opinion in Nephrology and Hypertension|October 6, 2005
Use of home blood-pressure monitoring in the detection, treatment and surveillance of hypertensionGillian Manning, Richard Donnelly
Diabetes, Obesity & Metabolism|April 2, 2004
Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?Rustam Rea, Richard Donnelly
Diabetes, Obesity & Metabolism|August 16, 2002
Treating peripheral arterial disease in patients with diabetesNorbert Hittel, Richard Donnelly
Journal of Hypertension|June 21, 2003
Microalbuminuria: how informative and reliable are individual measurements?Richard Donnelly, Rustam Rea
Diabetes & Vascular Disease Research|December 13, 2006
Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathyIskandar Idris, Richard Donnelly
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|August 16, 2002
Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazolRichard Donnelly
Diabetes, Obesity & Metabolism|February 16, 2007
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetesRichard Donnelly
Diabetes, Obesity & Metabolism|January 25, 2003
Researching new treatments for obesity: from neuroscience to inflammationRichard Donnelly
Diabetes, Obesity & Metabolism|October 14, 2004
ACE inhibitors and cardiovascular protection in diabetesRichard Donnelly
International Journal of Molecular Sciences|November 3, 2020
Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary SyndromeXianqin Qu, Richard Donnelly
Current Opinion in Nephrology and Hypertension|October 6, 2005
Use of home blood-pressure monitoring in the detection, treatment and surveillance of hypertensionGillian Manning, Richard Donnelly
Diabetes, Obesity & Metabolism|April 2, 2004
Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?Rustam Rea, Richard Donnelly
Diabetes, Obesity & Metabolism|August 16, 2002
Treating peripheral arterial disease in patients with diabetesNorbert Hittel, Richard Donnelly
Journal of Hypertension|June 21, 2003
Microalbuminuria: how informative and reliable are individual measurements?Richard Donnelly, Rustam Rea
Diabetes & Vascular Disease Research|December 13, 2006
Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathyIskandar Idris, Richard Donnelly
Pageof 6